Cargando…
Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
Tiotropium bromide is the only long-acting muscarinic antagonist (LAMA) approved for treatment of patients aged ≥6 years old who have symptoms of uncontrolled asthma. Results from several clinical trials have found that once-daily inhaled tiotropium bromide is safe and efficacious in 6- to 17-year-o...
Autores principales: | Santamaria, Francesca, Ziello, Carla, Lorello, Paola, Bouchè, Cristina, Borrelli, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343620/ https://www.ncbi.nlm.nih.gov/pubmed/35928684 http://dx.doi.org/10.3389/fped.2022.896865 |
Ejemplares similares
-
Editorial: Difficult and Severe Asthma in Children
por: Bush, Andrew, et al.
Publicado: (2019) -
Editorial: Difficult and severe asthma in children, volume II
por: Ullmann, Nicola, et al.
Publicado: (2023) -
Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population
por: Licari, Amelia, et al.
Publicado: (2018) -
Frontiers Review: Severe Asthma in Adolescents
por: Warraich, Sara, et al.
Publicado: (2022) -
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
por: Price, David, et al.
Publicado: (2014)